Definition
- Malignant tumour of cartilage-producing cells
- Proximal femur
- Pelvic Girdle
- Knee
- Spine
- 20% of primary bone tumours
- 2nd in frequency to Osteosarcoma
- It has a wide range of biologic behavior
- Low grade (grade 1): <5% risk of metastasis
- Intermediate grade (grade 2): 20-30% risk of metastasis
- Dedifferentiated (grades 3 and 4): 70% risk of metastasis
- Mesenchymal: >50% risk of metastasis
- 6-8th Decade of Life
Classification
- Classified according to
- Histological grade & subtypes
- Primary & Secondary
- Central & Peripheral
(1) Histological Grade & subtypes
- Based on the histological appearance
- Conventional chondrosarcoma
- Hyaline or myxoid cartilage tumour of various grades
- Special types
- Clear cell
- Mesenchymal
- Soft tissue chondrosarcoma
- Chondrosarcoma of skull base
- De-differentiated
- Conventional chondrosarcoma
Conventional chondrosarcoma
Grade | Descriptions |
---|---|
1 Low Grade | Resembles normal cartilage cells with mild cellular atypia Least risk of metastasis Frequent calcification |
2 Medium Grade | Frequent double nuclei Atypia with plump cells Rare multinucleated giant cells Calcification |
3 High Grade | Most abnormal-appearing cartilage with highest risk of metastasis Marked atypia & mitotic figures Double nuclei & crowding of lacunae Frequent multinucleated giant cells No calcification |
- lesions in axial skeleton & proximal appendicular skeleton more likely to be malignant than distal limb lesions (ie. the digits)
- Most chondrosarcomas are grade 1 or 2
- Chondrosarcomas are occasionally grade 3
- The only tumour that has higher risk of metastasizing than Grade 3 is De-differentiated Chondrosarcoma
Clear cell chondrosarcoma
- Young adults 20-50 years
- M:F – 2:1
- Low grade usually
- Thought to be malignant counterpart of the benign chondrhttp://chondroblastomaoblastoma
- Hence “epiphyseal chondrosarcoma”
- Most common in
- Proximal humerus
- Proximal femur
- Involve the epiphyseal centre & metaphysis
- Histology
- Larger & more rounded tumour cells with clear or vacuolated cytoplasm (sheets of clear cells)
- Abundant intracellular glycogen
- Chondroid & osseous matrix with numerous osteoclast-like giant cells (may resemble renal cell carcinoma)
- Foci of calcification
Mesenchymal chondrosarcoma
- 2nd-3rd decade of life
- High-grade
- Less common than clear cell
- Most common in
- Rib
- Spine
- Pelvis
- Femur
- Can appear in soft tissues
- Histology
- Nodules of benign cartilage in background of undifferentiated small round cells (biphasic appearance)
- Small cell component has appearance of Haemangiopericytoma or Ewings
- 60% 5 year survival
Soft tissue chondrosarcoma
- Rare tumour
- Little about natural history
- Treated like other STS
Base of Skull chondrosarcoma
- Confused with chondroma of clivus
- Presents with neurological deficits
- Treated with curettage & irradiation
De-differentiated Chondrosarcoma
- High-grade
- Non-chondroid sarcoma
- 10% of all chondrosarcomas
- Usually arises from
- Benign cartilage lesion
- Low grade chondrosarcoma
- Consists of areas of malignant spindle cells that cannot be recognised of cartilage origin adjacent to areas of neoplastic chondrocytes surrounded by hyaline ± bizarre giant cells
- Cartilage matrix has tissue resembling
- Osteosarcoma
- Fibrosarcoma
- MFH
- Most malignant of chondrosarcoma & highest rate of metastasis
(2) Primary & Secondary Types
Primary
- Arise de novo (primary) – most
Secondary
- 1. From pre-existing cartilage lesions
- Osteocartilaginous exostosis
- Enchondroma (Ollier disease , Maffucci syndrome)
- Periosteal chondroma
- Chondroblastoma
- Chondromyxofibroma
- Synovial chondromatosis
- Earlier age of presentation than the primary tumours
- 2. From other cause
- Pagets
- Radiation
- Later presentation than the primary tumours
(3) Central & Peripheral
Central (Medullary)
- Arise from
- medullary canal
- Meta-diaphyseal
- Metaphysis extending into diaphysis
- Femur & Humerus most commonly
- Meta-diaphyseal
- medullary canal
- All primary types are central
- Secondary types usually arise from Enchondroma
Peripheral (Juxtacortical)
- Arise from the surface of bone
- Pelvic & Shoulder girdle
- Upper Femur & Humerus
- Ribs
- Majority secondary to Exostosis
Risk of malignant transformation
- Solitary osteochondroma < 1%
- Diaphyseal aclasia 1% per year
- Solitary enchondroma < 1%
- Multiple enchondroma (Ollier’s*, Marfucci’s) 20-30%
- Patients with Ollier’s disease have 25% incidence of chondrosarcoma in lifetime
- Patients with Maffucci syndrome have 100% incidence of chondrosarcoma in lifetime
- Synovial chondromatosis 5%
Clinical features
- Classically patients in 5th-6th decades
- 4% < 20yo
- M:F – 1.5:1
- Long history of pain & mass
- Most commonly seen in medullary cavity of
- Femur
- Humerus
- Pelvis (incl. acetabulum)
- Ribs
- Patients initially complain of mild local pain & swelling
- Laboratory findings normal
Radiography
Central
- Diaphyseal or less often Metaphyseal
- Lucent expansile lesion
- Sclerotic margins
- Endosteal scalloping
- Intralesional calcification
- Amorphous
- Punctate
- Chicken Wire
- Popcorn
- Cortical destruction & soft tissue mass may be present
- More destructive lesions have
- Less calcification
- More scalloping
- More cortical destruction
Peripheral
- Soft tissue mass
- Multiple calcific densities
- Ill-defined margins
- Destruction of underlying bone
- Some are using Thallium & DMSA scans to differentiate low from high grade lesions
- uptake suggests ↑ metabolic activity (ie. high grade lesion)
- Approach to CLUMP lesions
- Bone scan cold
- expect good histological characteristics
- no need to biopsy
- Bone scan hot
- may have worrying histological features
- MRI with gadolinium producing a contrast enhancement curve with images taken at a specific site every 7 seconds for 2 minutes
- if there is a steep curve (rapid take-off) then suggestive of angiogenesis which may indicate aggressive lesion
- if so then should consider biopsy
- Bone scan cold
Histology
Gross
- Pearly white
- Cauliflower-like mass
- Surrounded by pseudocapsule
Histology
- Lobules of cartilage
- Matrix may have
- Calcification
- Necrosis
- Myxoid degeneration
- Features that suggest malignancy
- Pleomorphism
- Hypercellularity
- Mitotic figures
- Double nuclei in single lacunae
- Multinucleated Giant Cells
- Realise that the pathologist will accept chondromas with atypical features (↑ cellularity, binucleate cells, anaplasia etc) for certain lesions & still call them benign
- Solitary enchondroma
- Olliers or Marfucci’s
- Periosteal chondroma
- Synovial chondromatosis
- Some chondromas are indistinguishable from low grade chondrosarcoma
- 50% of Grade I chondrosarcomas are indistinguishable from cellular enchondroma
- Distinction is made on the radiological appearance (bone destruction etc), soft tissue extension, location etc
- Enchondromas & periosteal chondromas should be reviewed every year to see if they progress or change (particularly if multiple or part of a syndrome)
Genetics
- Numerous chromosomes have been implicated
- Patients with hereditary multiple exostoses and an EXT1 mutation are at higher risk than are patients with an EXT2 or EXT3 mutation
- Myxoid chondrosarcoma is associated with a 9-22 chromosomal translocation
Grading
- Grading based on complete patient
- Age
- Location
- XR
- Histology (see above)
- More likely to be worrisome if
- Central
- Large
- Old patient
- Polyploid
Differential Diagnosis
- Other cartilage tumours
- Chondrosarcomatous osteosarcoma
Treatment
- The mainstay of treatment is wide surgical resection
- Highly resistant to chemotherapy & radiotherapy
- Rate of DNA synthesis slow
- Slow growing, low grade nature of tumours
- Surgery should aim to be curative but sometimes margins are close d/t location of neurovascular structures
- Aggressive excision with wide margin
- Probably safest regardless of grade
- Adjunctive treatment rarely used
- May be indicated in
- High grade lesions
- Incomplete margins
- Phenol to lyse remaining tumour cells then neutralised with alcohol
- Irradiation most useful where wide resection not possible (eg. spine)
- High dose irradiation can arrest growth of the tumour for several years but will only delay the local recurrence
- Chemotherapy has been limited to the young patient with de-differentiated chondrosarcoma
- Little data to support usage & in metastatic disease will slow growth but cure rare
Prognosis
- Low-Moderate Grade
- If treated with wide excision
- 90% 5-year survival
- High Grade
- < 10% 5-year survival
- Thus patients with low grade tumours can expect a cure but metastasis common in high grade
- Depends on
- Histological grade
- Adequacy of resection